Analyst Reco. Aveanna Healthcare Holdings Inc.

Equities

AVAH

US05356F1057

Market Closed - Nasdaq Other stock markets 21:00:00 02/05/2024 BST			5-day change	1st Jan Change
2.27 ^USD	+1.79%		-1.73%	-15.30%

04-03	Aveanna Healthcare Holdings Inc Announces Appointment of Jerry Perchik to Serve as Chief Legal Officer and Secretary, Effective April 29, 2024	CI
03-18	Deutsche Bank Adjusts Aveanna Healthcare Price Target to $3 From $2, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Adjusts Aveanna Healthcare Price Target to $3 From $2, Maintains Buy Rating	03-18	MT
JPMorgan Downgrades Aveanna Healthcare to Underweight From Neutral	12-13	MT
UBS Initiates Coverage on Aveanna Healthcare With Sell Rating, $1.50 Price Target	11-30	MT
Deutsche Bank Adjusts Aveanna Healthcare Price Target to $2 From $1.70, Maintains Buy Rating	14/08/23	MT
RBC Boosts Price Target on Aveanna Healthcare Holdings to $3 From $2 After 'Solid' Q2 Results, Keeps Sector Perform Rating	14/08/23	MT
Truist Securities Adjusts Aveanna Healthcare Price Target to $1.70 From $1.40, Maintains Hold Rating	13/07/23	MT
Raymond James Downgrades Aveanna Healthcare Holdings to Market Perform From Strong Buy	12/05/23	MT
Aveanna Healthcare Receives Price Target Cut to $2 From $3 From RBC as 2023 EBITDA View Disappoints; Sector Perform Kept	20/03/23	MT
Raymond James Adjusts Price Target on Aveanna Healthcare to $3 From $4, Keeps Strong Buy Rating	20/03/23	MT
Truist Securities Adjusts Price Target on Aveanna Healthcare Holdings to $1.40 From $1, Maintains Hold Rating	17/03/23	MT
Deutsche Bank Lowers Price Target on Aveanna Healthcare to $1.70 From $3, Keeps Buy Rating	17/03/23	MT
Credit Suisse Downgrades Aveanna Healthcare Holdings to Underperform From Neutral, Notes High Leverage, Uncertain Timing of Turnaround; Trims PT to $1 From $2	27/01/23	MT
RBC Capital Downgrades Aveanna Healthcare Holdings to Sector Perform From Outperform, Adjusts Price Target to $3 From $7	21/11/22	MT
Credit Suisse Downgrades Aveanna Healthcare Holdings to Neutral From Outperform Given Debt Levels, Cuts PT to $2 From $5.50	17/11/22	MT
Raymond James Adjusts Price Target on Aveanna Healthcare Holdings to $4 From $6, Maintains Strong Buy Rating	16/11/22	MT
Stephens Adjusts Price Target on Aveanna Healthcare Holdings to $1.50 From $2.25, Maintains Equal-Weight Rating	11/11/22	MT
Barclays Adjusts Price Target on Aveanna Healthcare Holdings to $5 From $7, Reiterates Overweight Rating	19/08/22	MT
Raymond James Adjusts Price Target on Aveanna Healthcare Holdings to $6 From $8, Reiterates Strong Buy Rating	15/08/22	MT
Deutsche Bank Adjusts Price Target on Aveanna Healthcare Holdings to $3 From $6, Maintains Buy Rating	12/08/22	MT
Jefferies Downgrades Aveanna Healthcare Holdings to Hold From Buy, Adjusts Price Target to $2.50 From $9	22/07/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Aveanna Healthcare Holdings Inc.

Equities

AVAH

US05356F1057

Analyst Reco.

Filters